Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Miyajima Masaharu"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Negishi, Munehiro, Hiroki, Akihiro, Horikoshi, Yoichiro, Miyajima, Masaharu, Maekawa, Yasunari, Katakai, Ryoichi, Yoshida, Masaru
Publikováno v:
Pharmaceutical Development & Technology; May2001, Vol. 6 Issue 2, p173-179, 7p, 1 Chart
Autor:
Negishi, Munehiro, Hiroki, Akihiro, Horikoshi, Yoichiro, Miyajima, Masaharu, Asano, Masaharu, Katakai, Ryoichi, Yoshida, Masaru
Publikováno v:
Drug Development & Industrial Pharmacy; Apr99, Vol. 25 Issue 4, p437-444, 8p, 1 Chart
Autor:
Miyagawa, Yasuhiko, Sato, Hiroshi, Okabe, Toshio, Nishiyama, Tetsuyuki, Miyajima, Masaharu, Sunada, Hisakazu
Publikováno v:
Drug Development & Industrial Pharmacy; Apr99, Vol. 25 Issue 4, p429-435, 7p, 2 Charts
Autor:
Miyamoto, Yousuke, Ryu, Akio, Sugawara, Shinya, Miyajima, Masaharu, Ogawa, Shigeo, Matsui, Masayuki, Takayama, Kozo, Nagai, Tsuneji
Publikováno v:
Drug Development & Industrial Pharmacy; 1998, Vol. 24 Issue 11, p1055-1065, 11p
Autor:
Tsubuku, Satoru, Sugawara, Shinya, Miyajima, Masaharu, Yoshida, Masaru, Asano, Masaharu, Okabe, Kazuhiko, Kobayashi, Daishiro, Yamanaka, Hidetoshi
Publikováno v:
Drug Development & Industrial Pharmacy; 1998, Vol. 24 Issue 10, p927-934, 8p
Autor:
Kobayashi, Daishiro, Tsubuku, Satoru, Yamanaka, Hidetoshi, Asano, Masaharu, Miyajima, Masaharu, Yoshida, Masaru
Publikováno v:
Drug Development & Industrial Pharmacy; 1998, Vol. 24 Issue 9, p819-825, 7p
Autor:
Asano, Tomoaki, Tsubuku, Satoru, Sugawara, Shinya, Miyajima, Masaharu, Sato, Hiroshi, Yuasa, Hiroshi, Kanaya, Yoshio
Publikováno v:
Drug Development & Industrial Pharmacy; 1997, Vol. 23 Issue 7, p679-685, 7p
Autor:
Yoshida, Masaru, Asano, Masaharu, Omichi, Hideki, Miyajima, Masaharu, Takahashi, Yasuo, Yamanaka, Hidetoshi, Yonezawa, Noriyuki, Katakai, Ryoichi
Publikováno v:
Macromolecular Theory & Simulations; May1993, Vol. 2 Issue 3, p377-384, 8p
Publikováno v:
Journal of Controlled Release. 5:179-186
In order to develop a new transdermal delivery system providing variable drug delivery rates for antiviral Ara-A (9-β-arabino-furanosyladenine), it was first necessary to develop a method for designing rate-limiting polymeric membranes in transderma